wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38630749-5CAF0F49-E3FD-411E-BB31-61E56BF69AEF
Q38630749-5CAF0F49-E3FD-411E-BB31-61E56BF69AEF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38630749-5CAF0F49-E3FD-411E-BB31-61E56BF69AEF
TREATMENT PATTERNS AND 2-YEAR VISION OUTCOMES WITH BEVACIZUMAB IN DIABETIC MACULAR EDEMA: An Analysis From a Large U.S. Integrated Health Care System.
P2860
Q38630749-5CAF0F49-E3FD-411E-BB31-61E56BF69AEF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38630749-5CAF0F49-E3FD-411E-BB31-61E56BF69AEF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4c503e40d151adec4d0108dd1f72cc45968cf6b5
P2860
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.